Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Mon Mar 31 22:14:17 GMT 2025
by
admin
on
Mon Mar 31 22:14:17 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG1 |
| Sequence Type | COMPLETE |
| Record UNII |
2X3CKG601L
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C129823
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
||
|
NCI_THESAURUS |
C1512
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
CHEMBL3545372
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
Sofituzumab vedotin
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
BC-157
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
2X3CKG601L
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
1418200-58-4
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
DB15349
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
9861
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
300000025310
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY | |||
|
C106119
Created by
admin on Mon Mar 31 22:14:17 GMT 2025 , Edited by admin on Mon Mar 31 22:14:17 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_143 | 1_199 |
| 1_260 | 1_320 |
| 1_366 | 1_424 |
| 2_22 | 2_96 |
| 2_143 | 2_199 |
| 2_260 | 2_320 |
| 2_366 | 2_424 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| 1_219 | 3_214 |
| 2_219 | 4_214 |
| 1_225 | 2_225 |
| 1_228 | 2_228 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TOXIN -> CONJUGATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO ACID SUBSTITUTION | CYSTEINE |
Amount:
|
Cysteinyl vedotin | 6603L01WUR |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|